Letter: Don't blame patients
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Sir: The UK-based pharmaceutical industry fully agrees with Polly Toynbee (article, 6 October) when she seeks to provide an evidence-based basis for NHS treatment. But for the NHS to cut the medicines bill would end up costing far more than it would save.
Not only do doctors in the UK already prescribe fewer medicines than most of their counterparts abroad, but they also prescribe more generics, with well over 50 per cent of prescriptions now written generically. It is not true that the NHS pays more than any other country for medicines. Of 15 OECD countries, Britain is 14th in terms of expenditure on medicines per head, just above Ireland.
Over the past 40 years, advances in the use of medicines have helped to free up hospital beds by reducing the number of admissions by half for 12 major disease areas alone. The resulting annual saving of about pounds 10bn is double the cost of all NHS medicines.
While measures to restrict the availability of medicines might yield short-term savings, in the long term they will drive up costs in other sectors of healthcare, such as hospital surgery and community care. Medicines are part of the answer to the NHS's funding problems, not the cause.
Professor TREVOR M JONES
Director General
The Association of the British Pharmaceutical Industry
London SW1
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments